123 related articles for article (PubMed ID: 26515391)
1. Blocking TNF-α inhibits angiogenesis and growth of IFIT2-depleted metastatic oral squamous cell carcinoma cells.
Lai KC; Liu CJ; Lin TJ; Mar AC; Wang HH; Chen CW; Hong ZX; Lee TC
Cancer Lett; 2016 Jan; 370(2):207-15. PubMed ID: 26515391
[TBL] [Abstract][Full Text] [Related]
2. Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells.
Lai KC; Liu CJ; Chang KW; Lee TC
Oncogene; 2013 Aug; 32(32):3686-97. PubMed ID: 22986528
[TBL] [Abstract][Full Text] [Related]
3. IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma.
Lai KC; Chang KW; Liu CJ; Kao SY; Lee TC
Mol Cancer Res; 2008 Sep; 6(9):1431-9. PubMed ID: 18819931
[TBL] [Abstract][Full Text] [Related]
4. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
[TBL] [Abstract][Full Text] [Related]
5. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo.
Yasuda A; Kondo S; Nagumo T; Tsukamoto H; Mukudai Y; Umezawa K; Shintani S
Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660
[TBL] [Abstract][Full Text] [Related]
7. Humanized anti-interleukin-6 receptor antibody suppresses tumor angiogenesis and in vivo growth of human oral squamous cell carcinoma.
Shinriki S; Jono H; Ota K; Ueda M; Kudo M; Ota T; Oike Y; Endo M; Ibusuki M; Hiraki A; Nakayama H; Yoshitake Y; Shinohara M; Ando Y
Clin Cancer Res; 2009 Sep; 15(17):5426-34. PubMed ID: 19706815
[TBL] [Abstract][Full Text] [Related]
8. Application of a Persistent Heparin Treatment Inhibits the Malignant Potential of Oral Squamous Carcinoma Cells Induced by Tumor Cell-Derived Exosomes.
Sento S; Sasabe E; Yamamoto T
PLoS One; 2016; 11(2):e0148454. PubMed ID: 26849680
[TBL] [Abstract][Full Text] [Related]
9. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation.
Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B
Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035
[TBL] [Abstract][Full Text] [Related]
11. Granzyme B-truncated VEGF fusion protein represses angiogenesis and tumor growth of OSCC.
Lv XZ; Zheng MY; Lin ZQ; Zhao M; Wang H; Zeng WS
Oral Dis; 2016 Oct; 22(7):688-96. PubMed ID: 27291760
[TBL] [Abstract][Full Text] [Related]
12. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.
Park SJ; Kim MJ; Kim YK; Kim SM; Park JY; Myoung H
Cancer Lett; 2010 Jun; 292(1):54-63. PubMed ID: 19959278
[TBL] [Abstract][Full Text] [Related]
13. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
14. Modulation of growth and angiogenic potential of oral squamous carcinoma cells in vitro using salvianolic acid B.
Yang Y; Ge PJ; Jiang L; Li FL; Zhu QY
BMC Complement Altern Med; 2011 Jul; 11():54. PubMed ID: 21726465
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor alpha using RNA interference in oral squamous cell carcinoma.
Iulia Irimie A; Braicu C; Zanoaga O; Pileczki V; Soritau O; Berindan-Neagoe I; Septimiu Campian R
J BUON; 2015; 20(4):1107-14. PubMed ID: 26416064
[TBL] [Abstract][Full Text] [Related]
16. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
17. Effect of combining epidermal growth factor receptor inhibitors and cisplatin on proliferation and apoptosis of oral squamous cell carcinoma cells.
Takaoka S; Iwase M; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M; Shintani S
Int J Oncol; 2007 Jun; 30(6):1469-76. PubMed ID: 17487368
[TBL] [Abstract][Full Text] [Related]
18. The Iron Chelator, Dp44mT, Effectively Inhibits Human Oral Squamous Cell Carcinoma Cell Growth in Vitro and in Vivo.
Lee JC; Chiang KC; Feng TH; Chen YJ; Chuang ST; Tsui KH; Chung LC; Juang HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589737
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
Ahn MY; Kwon SM; Cheong HH; Park JH; Lee J; Min SK; Ahn SG; Yoon JH
J Oral Pathol Med; 2012 Aug; 41(7):540-6. PubMed ID: 22577802
[TBL] [Abstract][Full Text] [Related]
20. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
